BIBLIOGRAPHIC RECORD
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Shahram Attarian; Jean‐Michel Vallat; Laurent Magy; Benoît Funalot; Pierre‐Marie Gonnaud; Arnaud Lacour; Yann Péréon; O. Dubourg; Jean Pouget; Joëlle Micallef; Jérome Franques; Marie‐Noëlle Lefebvre; Karima Ghorab; Mahmoud Al-Moussawi; V. Tiffreau; Marguerite Preudhomme; Armelle Magot; Laurène Leclair‐Visonneau; Tanya Stojkovic; Laura Bossi; Philippe Lehert; Walter Gilbert; Viviane Bertrand; Jonas Mandel; Aude Milet; Rodolphe Hajj; Lamia Boudiaf; Catherine Scart‐Grès; Serguei Nabirotchkin; Mickaël Guedj
- Source of metadata
- OpenAlex
- Year recorded
- 2014
Public identifiers and source
Open the source recordReference
Shahram Attarian; Jean‐Michel Vallat; Laurent Magy; Benoît Funalot; Pierre‐Marie Gonnaud; Arnaud Lacour; Yann Péréon; O. Dubourg; Jean Pouget; Joëlle Micallef; Jérome Franques; Marie‐Noëlle Lefebvre; Karima Ghorab; Mahmoud Al-Moussawi; V. Tiffreau; Marguerite Preudhomme; Armelle Magot; Laurène Leclair‐Visonneau; Tanya Stojkovic; Laura Bossi; Philippe Lehert; Walter Gilbert; Viviane Bertrand; Jonas Mandel; Aude Milet; Rodolphe Hajj; Lamia Boudiaf; Catherine Scart‐Grès; Serguei Nabirotchkin; Mickaël Guedj. (2014). An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. https://openalex.org/W2137894294
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-307ca6f1a04aba1bc96bb8afbf6ed177/